(4S)-(+)-N-(3,5-Dimethoxyphenyl)-4-phenyl-6,7-dihydrothieno-[3,2-c]pyridine-5(4H)-carboxamide

ID: ALA4461980

PubChem CID: 155528786

Max Phase: Preclinical

Molecular Formula: C22H22N2O3S

Molecular Weight: 394.50

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(NC(=O)N2CCc3sccc3[C@@H]2c2ccccc2)cc(OC)c1

Standard InChI:  InChI=1S/C22H22N2O3S/c1-26-17-12-16(13-18(14-17)27-2)23-22(25)24-10-8-20-19(9-11-28-20)21(24)15-6-4-3-5-7-15/h3-7,9,11-14,21H,8,10H2,1-2H3,(H,23,25)/t21-/m0/s1

Standard InChI Key:  XFVVCCFUPHXUCI-NRFANRHFSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
    9.5030  -12.3993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2108  -11.9918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9185  -12.3993    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.9185  -13.2184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2108  -13.6300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5030  -13.2184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7247  -13.4726    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.2435  -12.8108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7248  -12.1492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6301  -11.9920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6301  -11.1733    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.3375  -12.3993    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.0449  -11.9920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0453  -11.1732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7502  -10.7645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4621  -11.1761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4643  -11.9890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7567  -12.4018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1718  -12.4004    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.8792  -11.9890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7502   -9.9499    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.4618   -9.5384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2108  -11.1731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5034  -10.7654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5045   -9.9502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2122   -9.5386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9158   -9.9452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9226  -10.7633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  6  5  1  0
  1  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  1  9  1  0
  3 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 14 13  2  0
 15 14  1  0
 16 15  2  0
 17 16  1  0
 18 17  2  0
 13 18  1  0
 17 19  1  0
 19 20  1  0
 15 21  1  0
 21 22  1  0
  2 23  1  6
 24 23  2  0
 25 24  1  0
 26 25  2  0
 27 26  1  0
 28 27  2  0
 23 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4461980

    ---

Associated Targets(Human)

LHCGR Tclin Luteinizing hormone/Choriogonadotropin receptor (373 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 394.50Molecular Weight (Monoisotopic): 394.1351AlogP: 4.94#Rotatable Bonds: 4
Polar Surface Area: 50.80Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.61CX Basic pKa: CX LogP: 4.47CX LogD: 4.47
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.68Np Likeness Score: -1.58

References

1. Wortmann L, Lindenthal B, Muhn P, Walter A, Nubbemeyer R, Heldmann D, Sobek L, Morandi F, Schrey AK, Moosmayer D, Günther J, Kuhnke J, Koppitz M, Lücking U, Röhn U, Schäfer M, Nowak-Reppel K, Kühne R, Weinmann H, Langer G..  (2019)  Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in Vivo.,  62  (22): [PMID:31670515] [10.1021/acs.jmedchem.9b01382]

Source